Beta-catenin expression in pediatric fibroblastic and myofibroblastic lesions: A study of 100 cases

Pediatric and Developmental Pathology

Volumn 12, Issue 4, 2009, Pages 292-296

  Thway, Khin ^a   Gibson, Sian ^b   Ramsay, Alan ^c   Sebire, Neil J ^b  

^a ROYAL MARSDEN HOSPITAL   (United Kingdom)

^b GREAT ORMOND STREET HOSPITAL   (United Kingdom)

^c UNIVERSITY COLLEGE HOSPITAL   (United Kingdom)

Author keywords

Beta catenin; Fibromatosis; Immunohistochemistry; Pediatric; Soft tissue neoplasm

Indexed keywords

BETA CATENIN;

ADOLESCENT; ARTICLE; CALCIFYING APONEUROTIC FIBROMA; CHILD; CONTROLLED STUDY; FEMALE; FIBROBLAST; FIBROMATOSIS; FIBROMATOSIS COLLI; HAMARTOMA; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INFANT; LEIOMYOMA; LIPOFIBROMA; MAJOR CLINICAL STUDY; MALE; MYOFIBROBLAST; PALMAR PLANTAR FIBROMATOSIS; PRESCHOOL CHILD; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; SCHOOL CHILD; STAINING; TORTICOLLIS;

ADOLESCENT; BETA CATENIN; CHILD; CHILD, PRESCHOOL; FIBROMA; HUMANS; IMMUNOHISTOCHEMISTRY; INFANT; INFANT, NEWBORN; SOFT TISSUE NEOPLASMS; TUMOR MARKERS, BIOLOGICAL;

EID: 70049095654     PISSN: 10935266     EISSN: 16155742     Source Type: Journal    
DOI: 10.2350/08-07-0506.1     Document Type: Article

References (16)

1. Eccles DM, van der Luijt R, Breukel C, et al. Hereditary desmoid disease due to a frameshift mutation at codon 1924 of the APC gene. Am J Hum Genet 1996;59:1193-1201.
2. Scott RJ, Froggatt NJ, Trembath RC, Evans DG, Hodgson SV, Maher ER. Familial infiltrative fibromatosis (desmoid tumours) (MIM135290) caused by a recurrent 3′ APC gene mutation. Hum Mol Genet 1996;5:1921-1924.
3. Alman BA, Li C, Pajerski ME, Diaz-Cano S, Wolfe HJ. Increased beta-catenin protein and somatic APC mutations in sporadic aggressive fibromatoses (desmoid tumors). Am J Pathol 1997;151:329-334. (Pubitemid 27330053)
4. Tejpar S, Nollet F, Li C, et al. Predominance of beta-catenin mutations and beta-catenin dysregulation in sporadic aggressive fibromatosis (desmoid tumor). Oncogene 1999;18:6615-6620.
5. Montgomery E, Lee JH, Abraham SC, Wu TT. Superficial fibromatoses are genetically distinct from deep fibromatoses. Mod Pathol 2001;14:695-701. (Pubitemid 32667214)
6. Montgomery E, Torbenson MS, Kaushal M, Fisher C, Abraham SC. Beta-catenin immunohistochemistry separates mesenteric fibromatosis from gastrointestinal stromal tumor and sclerosing mesenteritis. Am J Surg Pathol 2002;26:1296-1301.
7. Coffin CM, Dehner LP. Fibroblastic-myofibroblastic tumors in children and adolescents: a clinicopathologic study of 108 examples in 103 patients. Pediatr Pathol 1991;11:569-588.
8. Ng TL, Gown AM, Barry TS, et al. Nuclear beta-catenin in mesenchymal tumors. Mod Pathol 2005;18:68-74.
9. Carlson JW, Fletcher CD. Immunohistochemistry for beta-catenin in the differential diagnosis of spindle cell lesions: analysis of a series and review of the literature. Histopathology 2007;51:509-514.
10. Weiss SW, Goldblum JR. Fibrous tumors of infancy and childhood. In: SW Weiss, JR Goldblum, eds. Enzinger and Weiss's Soft Tissue Tumors, 5th ed. Philadelphia: Mosby Elsevier, 2008;257-302.
11. Goldblum J, Fletcher JA. Desmoid-type fibromatoses. In: CDM Fletcher, KK Unni, F Mertens, eds. World Health Organisation Classification of Tumours. Pathology and Genetics of Tumours of Soft Tissue and Bone. Lyon: IARC Press, 2002;83-84.
12. Abraham SC, Reynolds C, Lee JH, et al. Fibromatosis of the breast and mutations involving the APC/beta-catenin pathway. Hum Pathol 2002;33:39-46. (Pubitemid 34112951)
13. Bhattacharya B, Dilworth HP, Iacobuzio-Donahue C, et al. Nuclear beta-catenin expression distinguishes deep fibromatosis from other benign and malignant fibroblastic and myofibroblastic lesions. Am J Surg Pathol 2005;29:653-659. (Pubitemid 40577876)
14. Reitamo JJ, Hayry P, Nykyri E, Saxen E. The desmoid tumor. I. Incidence, sex-, age- and anatomical distribution in the Finnish population. Am J Clin Pathol 1982;77:665-673.
15. Dvory-Sobol H, Sagiv E, Liberman E, Kazanov D, Arber N. Suppression of gastric cancer cell growth by targeting the beta-catenin/T-cell factor pathway. Cancer 2007;109:188-197. (Pubitemid 46106233)
16. Dvory-Sobol H, Sagiv E, Kazanov D, Ben-Ze'ev A, Arber N. Targeting the active beta-catenin pathway to treat cancer cells. Mol Cancer Ther 2006;5:2861-2871.